[1] Weber GF. Why does cancer therapy lack effective anti-metastasis drugs? [J]. Cancer Lett, 2013, 328(2): 207-211. [2] Turajlic S, Swanton C. Metastasis as an evolutionary process [J]. Science, 2016, 352(6282): 169-175. [3] Simpson CD, Anyiwe K, Schimmer AD. Anoikis resistance and tumor metastasis [J]. Cancer Lett, 2008, 272(2): 177-185. [4] Bunek J, Kamarajan P, Kapila YL. Anoikis mediators in oral squamous cell carcinoma [J]. Oral Dis, 2011, 17(4): 355-361. [5] Sanchez-Ruderisch H, Detjen KM, Welzel M, et al. Galectin-1 sensitizes carcinoma cells to anoikis via the fibronectin receptor alpha5beta1-integrin [J]. Cell Death Differ, 2011, 18(5): 806-816. [6] Gilmore AP. Anoikis [J]. Cell Death Differ, 2005, 12(Suppl 2): 1473-1477. [7] Wang X, Cui M, Wang L, et al. Inhibition of neurotrophin receptor p75 intramembran proteolysis by gamma-secretase inhibitor reduces medulloblastoma spinal metastasis [J]. Biochem Biophys Res Commun, 2010, 403(3-4): 264-269. [8] Truzzi F, Marconi A, Lotti R, et al. Neurotrophins and their receptors stimulate melanoma cell proliferation and migration [J]. J Invest Dermatol, 2008, 128(8): 2031-2040. [9] Khwaja F, Djakiew D. Inhibition of cell-cycle effectors of proliferation in bladder tumor epithelial cells by the p75NTR tumor suppressor [J]. Mol Carcinog, 2003, 36(3): 153-160. [10] Khwaja F, Tabassum A, Allen J, et al. The p75(NTR) tumor suppressor induces cell cycle arrest facilitating caspase mediated apoptosis in prostate tumor cells [J]. Biochem Biophys Res Commun, 2006, 341(4): 1184-1192. [11] Kwak T, Drews-Elger K, Ergonul A, et al. Targeting of RAGE-ligand signaling impairs breast cancer cell invasion and metastasis [J]. Oncogene, 2017, 36(11): 1559-1572. [12] Bilderback TR, Gazula VR, Dobrowsky RT. Phosphoinositide 3-kinase regulates crosstalk between Trk A tyrosine kinase and p75(NTR)-dependent sphingolipid signaling pathways[J]. J Neurochem, 2001, 76(5): 1540-1551. |